NASDAQ$JYNT
The Joint Corp · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
The Joint Corp. reported Q3 2024 financial results.
The Joint Corp. reported a 2% increase in revenue to $30.2 million, but net loss was $3.2 million, including $3.8 million in loss on disposition or impairment. System-wide sales increased 8% to $129.3 million.
- Revenue grew 2% to $30.2 million.
- Net loss was $3.2 million, including $3.8 million in loss on disposition or impairment.
- Adjusted EBITDA was $2.4 million.
- System-wide sales increased 8% to $129.3 million.
Headline financials
Revenue & EPS history
The Joint · Revenue · Quarterly
$30.2M
Forward guidance
The company adjusted its guidance to account the potential impact of ongoing consumer headwinds.
Tailwinds
- System-wide sales are expected to be between $525 million and $535 million.
- System-wide comp sales for all clinics open 13 months or more are expected to be between 3% and 4%.
- New franchised clinic openings, excluding the impact of refranchised clinics, are expected to be between 55 and 60.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
+1.5%
Avg return
Earnings day
+3.3%
Avg return
5 days after
+3.8%
Avg return
30 days after
53%
25 / 47 earnings
Positive
+26.0%
Q1 2024
Best reaction
-42.3%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -2.2% | -6.0% | |
| Q4 2025 | +2.0% | +1.9% | +6.3% | |
| Q3 2025 | -3.9% | +4.6% | +6.1% | |
| Q1 2025 | -5.0% | -5.2% | +14.1% | |
| Q4 2024 | +4.6% | +17.9% | -1.3% | |
| Q3 2024 | -2.8% | -1.7% | -3.1% | |
| Q2 2024 | -5.1% | -3.6% | -8.7% | |
| Q1 2024 | +26.0% | +26.1% | +17.4% | |
| Q4 2023 | +25.7% | +29.8% | +34.8% | |
| Q3 2023 | +1.3% | +4.6% | +15.1% | |
| Q2 2023 | +1.8% | -0.2% | -14.6% | |
| Q1 2023 | -3.1% | -2.2% | -11.2% | |
| Q4 2022 | +2.3% | +1.4% | -1.2% | |
| Q3 2022 | -4.6% | -3.3% | +1.6% | |
| Q2 2022 | +15.2% | +7.8% | -9.6% | |
| Q1 2022 | -42.3% | -43.6% | -46.2% | |
| Q4 2021 | -9.9% | -20.8% | -24.7% | |
| Q3 2021 | +5.8% | +8.6% | -21.8% | |
| Q2 2021 | +18.9% | +17.8% | +22.0% | |
| Q1 2021 | -4.5% | -6.8% | +28.2% | |
| Q4 2020 | -10.0% | -14.9% | -7.0% | |
| Q3 2020 | +7.1% | +28.5% | +35.2% | |
| Q2 2020 | +13.5% | +15.1% | +23.7% | |
| Q1 2020 | +9.9% | +8.8% | +35.6% | |
| Q4 2019 | -3.0% | -10.8% | -42.2% | |
| Q3 2019 | -3.6% | -10.3% | -13.1% | |
| Q2 2019 | -0.1% | +0.0% | -6.2% | |
| Q1 2019 | +8.7% | +4.4% | -7.2% | |
| Q4 2018 | +12.6% | +21.5% | +42.4% | |
| Q3 2018 | +3.8% | +5.5% | +0.5% | |
| Q2 2018 | +8.5% | +3.9% | +2.8% | |
| Q1 2018 | -3.0% | +1.8% | +1.9% | |
| Q4 2017 | +8.2% | +23.7% | +35.9% | |
| Q3 2017 | +16.2% | +23.0% | +8.6% | |
| Q2 2017 | +3.6% | +2.7% | +34.5% | |
| Q1 2017 | +7.3% | +2.6% | -1.3% | |
| Q4 2016 | -15.3% | -11.4% | -15.8% | |
| Q3 2016 | +3.7% | +6.1% | -6.5% | |
| Q2 2016 | -0.5% | -0.9% | +28.9% | |
| Q1 2016 | -0.0% | — | — | |
| Q4 2015 | -21.5% | — | — | |
| Q3 2015 | -6.1% | — | — | |
| Q2 2015 | +1.3% | — | — | |
| Q1 2015 | +6.2% | — | — | |
| Q4 2014 | +4.0% | — | — | |
| Q3 2014 | -1.6% | — | — | |
| Q3 2013 | -1.6% | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro